# OnCo record carrick-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/carrick-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "carrick-therapeutics" ;
  schema:name "Carrick Therapeutics"@en ;
  schema:alternateName "Carrick Therapeutics, Inc."@en, "Carrick Therapeutics Limited"@en ;
  schema:description "Carrick Therapeutics develops medicines taken by mouth that block enzymes cancer cells use to grow. Its lead drug, samuraciclib, is being tested with hormone therapy in advanced hormone receptor-positive, HER2-negative breast cancer after earlier treatment has stopped working."@en ;
  schema:url <https://onco.cc/companies/carrick-therapeutics/>, <https://www.carricktherapeutics.com/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.carricktherapeutics.com/>, <https://www.carricktherapeutics.com/pipeline>, <https://www.carricktherapeutics.com/pipeline/cdk7-inhibitor>, <https://www.carricktherapeutics.com/pipeline/cdk1213-inhibitor>, <https://www.carricktherapeutics.com/news-media/press-releases/detail/27/carrick-therapeutics-announces-positive-results-from-phase>, <https://www.carricktherapeutics.com/news-media/press-releases/detail/24/carrick-therapeutics-establishes-new-headquarters-in>, <https://web.archive.org/web/20261016142320/https://www.archventure.com/portfolio/> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/breast-hr-positive/>, <https://onco.cc/cancers/hr-positive-metastatic-post-cdk46/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/> ;
  onco:technologies <https://onco.cc/technologies/protac-degrader/> ;
  onco:targets <https://onco.cc/targets/cdk12/> ;
  onco:drugs <https://onco.cc/drugs/samuraciclib/>, <https://onco.cc/drugs/ct7439/> ;
  onco:trials <https://onco.cc/trials/nct06600789/> .
